Market
Research Future published a Half-Cooked Research Report on “Global Cholesterol
Management Devices Market Research Report - Forecast to 2027” – Market
Analysis, Scope, Stake, Progress, Trends and Forecast to 2027.
Cholesterol management devices is the monitoring devices for
the determination of the cholesterol levels in the body. Cholesterol is one of
the vital constituent of the cells. However, increase in the cholesterol level
may led to atherosclerosis, cardiovascular diseases, heart attack and other
disease. The global cholesterol management devices market is driven by rapidly
development in the cholesterol monitoring devices, and increasing people
suffering from obesity. Moreover, affordability of the devices, poor diet and
physical activity, desk-bound nature of work, changing modes of transportation,
and increasing urbanization has also contributed in the growth of the market.
However, lack of awareness may obstruct the growth of the market. The global
cholesterol management devices market is growing at a CAGR of 8.5% during the
forecasted period. Cardiovascular diseases gain a huge attention due to
increasing prevalence. Furthermore, due to increasing number of death from
cardiovascular diseases, number of companies are in a race for the introduction
of the better devices and accessories for the treatment.
Diabetes & obesity are the major causes for
cardiovascular diseases. Increasing number of patients suffering from these
diseases lead to increase in the prevalence of cardiovascular diseases,
ultimately increase the demand for the cardiovascular devices which will fuel
the growth of the market.
According to the World Health Organization (WHO), in 2015,
over 17.7 million people died from cardiovascular diseases, representing 31% of
all global deaths. According to findings from the WHO, in 2015, 82% of the
total deaths were occurred in low- and middle-income countries.
According to findings from the WHO in 2014, approximately
422 million people suffered from diabetes. Beside this, globally 39% of adults
aged 18 years and over were overweight in 2016, and 13% were obese.
Global
Cholesterol Management Devices Market - Competitive Analysis:
The global cholesterol management devices market is
experiencing extreme competition due to major companies are focusing on the
development of new and advances monitoring devices to overcome the
disadvantages of other available devices. Some major has adopted strategies of
acquisitions and strategic alliances for the growth of the market.
Abbott, headquartered in the U.S., is one of the leading
healthcare company. The company manufacturers, ARCHITECT, which is a clinical
chemistry analyser and provides excellent first-time results. The company
performs a number of tests for high density lipoprotein (HOL), low density
lipoprotein (LDL), and triglycerides.
Medtronic, headquartered in UK, is a world's largest
standalone medical device manufacturer. The company has launched number of
portable monitoring devices and monitors used in the hospitals. In 2015, the
company has completed its acquisition of Covidien.
Global
Cholesterol Management Devices Market - Regional Analysis:
Geographically, the global cholesterol management devices
market is categorized into Americas, Europe, Asia Pacific and Middle East &
Africa. Americas accounts for the largest share in the market followed by
Europe. Presence of huge people suffering from obesity and hypercholesterolemia
has driven the growth of market in America. According to the Centers for
Disease Control and Prevention (2015), over 630,000 Americans die from heart
disease each year, which accounted for 1 in every 4 deaths. Furthermore, the
reimbursement policies cover more than 75% of the cost of the devices and
treatment. For instance, under the Medicare plan in the U.S., if the average
cost of the single chamber devices is approximately USD 10,000, then USD 7,500
is reimbursed. Additionally, in developed countries like U.K, Canada, Germany,
and other similar reimbursement policies are available.
While, government support for research and development, well
developed technology and high healthcare expenditure has uplifted the growth of
the market in Europe. Asia pacific experience the fastest growth for the market
owing to the presence of rapidly growing economies, huge population base and
lot of opportunities for the development of the market. The Middle East &
Africa holds the least share of the global market due to limited availability
of medical facilities and poor economic condition in the African region. The
Middle East holds the major share in the market owing to a well-developed
economy, whereas, Africa region is expecting a healthy growth due to the
presence of huge opportunity in the market growth.
Key
Players for Global Cholesterol Management Devices Market:
Some of the key player in the market are Boston Scientific
Corporation (US), Medtronic (US), St. Jude Medical, LLC. (Canada), Koninklijke
Philips N.V. (US), Roche Diagnostics (US), Abbott (US), Alere (US), Sorin Group
(Italy), BIOTRONIK SE & Co. KG (Germany), Bio-AMD (UK) and others.
Major TOC
of Cholesterol Management Devices Market Research Report - Global forecast till
2023:
1 REPORT
PROLOGUE
2
MARKET INTRODUCTIONS
2.1 Introduction
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3
RESEARCH METHODOLOGIES
3.1.1 Primary Research Methodology
3.1.2 Secondary Research Methodology
3.1.3 Market Share Analysis
3.1.4 Trade Analysis
3.2 Forecast Model
4
MARKET DYNAMICS
4.1 Introduction
4.2 Drivers
4.2.1 Rising Prevalence Of Chronic Disease
4.2.2 Growing Awareness About Cholesterol Management
Devices
4.2.3 Increasing Demand For Innovative Medical Devices
And Sensors
4.3 Restraints
TOC
Continued…!
LIST OF TABLES
Table 1 Cholesterol Management Devices Industry
Synopsis, 2017–2023
Table 2 Global Cholesterol Management Devices Market
Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Global Cholesterol Management Devices Market,
By Region, 2017–2023, (USD Million)
Table 4 Global Cholesterol Management Devices Market,
By Types, 2017–2023, (USD Million)
Table 5 Global Cholesterol Management Devices Market,
By Application, 2017–2023, (USD Million)
Table 6 Global Cholesterol Management Devices Market,
By End User, 2017–2023, (USD Million)
Table 7 Americas Cholesterol Management Devices Market,
By Types, 2017–2023, (USD Million)
&
More…!
LIST
OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Cholesterol Management
Devices Market
Figure 3 Segmentation Market Dynamics For Cholesterol
Management Devices Market
Figure 4 Global Cholesterol Management Devices Market
Share, By Types, 2016
Figure 5 Global Cholesterol Management Devices Market Share,
By Application, 2016
Figure 6 Global Cholesterol Management Devices Market
Share, By End User, 2016
Figure 7 Global Cholesterol Management Devices Market
Share, By Region, 2016
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment